Similar articles for PMID: 30212603

Year	Number of Results
2003	1
2005	1
2007	2
2008	1
2009	2
2010	5
2011	1
2012	4
2013	3
2014	11
2015	13
2016	15
2017	18
2018	16
2019	7
2020	5
2021	10
2022	3
2024	0

1

Preparation of Ligand-Targeted Drug Conjugates for Cancer Therapy and Their Evaluation In Vitro.

Krishnan MA, Sengupta S, Chelvam V. Krishnan MA, et al. Curr Protoc Chem Biol. 2018 Dec;10(4):e50. doi: 10.1002/cpch.50. Epub 2018 Sep 13. Curr Protoc Chem Biol. 2018. PMID: 30212603

2

In Vivo Evaluation of Ligand Targeted Drug Conjugates for Cancer Therapy.

Krishnan MA, Pandit A, Chelvam V. Krishnan MA, et al. Curr Protoc Chem Biol. 2018 Dec;10(4):e49. doi: 10.1002/cpch.49. Epub 2018 Sep 13. Curr Protoc Chem Biol. 2018. PMID: 30212611

3

Advancements in folate receptor targeting for anti-cancer therapy: A small molecule-drug conjugate approach.

Rana A, Bhatnagar S. Rana A, et al. Bioorg Chem. 2021 Jul;112:104946. doi: 10.1016/j.bioorg.2021.104946. Epub 2021 Apr 27. Bioorg Chem. 2021. PMID: 33989916 Review.

4

PSMA-targeted small-molecule docetaxel conjugate: Synthesis and preclinical evaluation.

Machulkin AE, Uspenskaya AA, Zyk NY, Nimenko EA, Ber AP, Petrov SA, Shafikov RR, Skvortsov DA, Smirnova GB, Borisova YA, Pokrovsky VS, Kolmogorov VS, Vaneev AN, Ivanenkov YA, Khudyakov AD, Kovalev SV, Erofeev AS, Gorelkin PV, Beloglazkina EK, Zyk NV, Khazanova ES, Majouga AG. Machulkin AE, et al. Eur J Med Chem. 2022 Jan 5;227:113936. doi: 10.1016/j.ejmech.2021.113936. Epub 2021 Oct 23. Eur J Med Chem. 2022. PMID: 34717125

5

Chemistry and Chemical Biology of Therapeutically Important Compounds.

Disney MD. Disney MD. Bioorg Med Chem. 2016 Sep 1;24(17):3875. doi: 10.1016/j.bmc.2016.06.049. Epub 2016 Jun 27. Bioorg Med Chem. 2016. PMID: 27460698 No abstract available.

6

Structure-based design of HSPA5 inhibitors: from peptide to small molecule inhibitors.

Huang M, Li Z, Li D, Walker S, Greenan C, Kennedy R. Huang M, et al. Bioorg Med Chem Lett. 2013 May 15;23(10):3044-50. doi: 10.1016/j.bmcl.2013.03.035. Epub 2013 Mar 16. Bioorg Med Chem Lett. 2013. PMID: 23562057

7

Folate-vinca alkaloid conjugates for cancer therapy: a structure-activity relationship.

Leamon CP, Vlahov IR, Reddy JA, Vetzel M, Santhapuram HK, You F, Bloomfield A, Dorton R, Nelson M, Kleindl P, Vaughn JF, Westrick E. Leamon CP, et al. Bioconjug Chem. 2014 Mar 19;25(3):560-8. doi: 10.1021/bc400441s. Epub 2014 Mar 11. Bioconjug Chem. 2014. PMID: 24564229

8

Synthesis and anticancer evaluation of complex unsaturated isosteviol-derived triazole conjugates.

Khaybullin RN, Liang X, Cisneros K, Qi X. Khaybullin RN, et al. Future Med Chem. 2015;7(18):2419-28. doi: 10.4155/fmc.15.158. Epub 2015 Dec 11. Future Med Chem. 2015. PMID: 26653151 Free PMC article.

9

Delivering aminopyridine ligands into cancer cells through conjugation to the cell-penetrating peptide BP16.

Soler M, González-Bártulos M, Figueras E, Massaguer A, Feliu L, Planas M, Ribas X, Costas M. Soler M, et al. Org Biomol Chem. 2016 Apr 26;14(17):4061-70. doi: 10.1039/c6ob00470a. Org Biomol Chem. 2016. PMID: 27055538

10

Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.

Vo DD, Staedel C, Zehnacker L, Benhida R, Darfeuille F, Duca M. Vo DD, et al. ACS Chem Biol. 2014 Mar 21;9(3):711-21. doi: 10.1021/cb400668h. Epub 2014 Jan 3. ACS Chem Biol. 2014. PMID: 24359019

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

106 results

Results by year